Structure-activity relationship of dermorphin on gastric secretion

Area of Science:

• Pharmacology
• Gastroenterology
• Peptide Chemistry

Background:

• Amphibian skin peptides are a source of novel bioactive compounds.
• Dermorphin (DM) is a heptapeptide known for its potent biological activities.
• Understanding DM's effect on gastric secretion is crucial for potential therapeutic applications.

Purpose of the Study:

• To investigate the structure-activity relationship of dermorphin (DM) and its analogs on gastric secretion.
• To identify the minimal sequence and specific structural features required for DM's inhibitory effect on gastric acid output.

Main Methods:

• Intracerebroventricular administration of DM and 19 analogs to rats.
• Measurement of gastric volume, pH, H+ ion concentration, and gastric acid output.
• Comparative analysis of the effects of various DM modifications on gastric secretion parameters.

Main Results:

• DM and several analogs, including N-terminal fragments and specific substitutions like [D-Met2]DM and [Gly7]DM, significantly reduced gastric acid output.
• The D-isomer of Alanine at position 2 is essential for DM's inhibitory activity, as [L-Ala2]DM was inactive.
• The shortest active sequence identified was the DM N-terminal tetrapeptide amide.
• Single amino acid substitutions resulted in a wide spectrum of activities, with some analogs being inactive ([Pro4]DM, [Gly6]DM).
• Protective group coupling to DM led to a significant loss of activity.

Conclusions:

• Dermorphin's ability to inhibit gastric secretion is critically dependent on the D-isomer of Alanine at position 2.
• The N-terminal tetrapeptide amide represents the shortest bioactive sequence of DM.
• Specific amino acid substitutions profoundly influence DM's bioactivity, highlighting the importance of precise structural integrity.
• Chemical modifications like protective group coupling diminish DM's gastric inhibitory effects.